Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Andrographis paniculata extract × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Cyclophosphamide 1287 Cisplatin 1227 Radiotherapy 1159 Paclitaxel 1154 Carboplatin 1090 Gemcitabine 1064 Docetaxel 984 Bevacizumab 928 Fluorouracil 783 Doxorubicin 695 Capecitabine 661 Dexamethasone 654 Rituximab 643 Oxaliplatin 613 Etoposide 585 pembrolizumab 571 Irinotecan 559 Filgrastim 543 Leucovorin 511 Cytarabine 506 Nivolumab 483 Vincristine 441 Bortezomib 419 Cetuximab 416 Prednisone 410 Erlotinib Hydrochloride 403 Trastuzumab 400 Surveys and Questionnaires 390 Methotrexate 372 Lenalidomide 369

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04196075 2021-11-08

AP

Chinese University of Hong Kong

Phase 3 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡